SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, today announced that Chief Executive Officer Dr. Stephen Chang will be one of the featured presenters this week at the New York Academy of Sciences (NYAS) conference to explore new treatments for type-1 diabetes and multiple sclerosis (MS).
